2013-11-CALR

Text Size

Share this page on any of these social networking sites:
Share this page on any of these social networking sites: LinkedIn

 

Law Reporter Products

  • Abstract Sets
  • Court Documents
  • Injury Collections

Get More Info »

Search the Exchange »

November 2013

Case in Point

Investors settle securities claims against manufacturer of obesity drug

The plaintiffs claimed the drugmaker and multiple executives issued misleading statements to artificially inflate the stock price in violation of the Securities and Exchange Act. The defendants settled for $40 million. In re Sanofi-Aventis Secs. Litig.

 

The American Association for Justice
777 6th Street, NW, Ste 200 • Washington, DC  20001 • 800.424.2725 or 202.965.3500

© 2014 AAJ